High Tide Opens New Canna Cabana Location in Drayton Valley, Alberta

High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 4341 50 Street in Drayton Valley, Alberta, has begun selling recreational cannabis products and consumption accessories […]

Crawford United Corporation Announces Second Quarter 2025 Results

Crawford United Corporation Announces Second Quarter 2025 Results GlobeNewswire July 31, 2025 Earnings per share of $1.44 for the quarter and $2.32 year-to-date Sales of $46.9 million for the quarter, an increase of 24.5% from the prior year quarter Net income of $5.1 million for the quarter and $8.3 million year-to-date EBITDA As Defined1 of

GCL Announces Fiscal Year 2025 Financial Results

(NASDAQ:GCL),(NASDAQ:GCLWW), SINGAPORE, July 31, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced its financial results for the fiscal year ended March 31, 2025. FY2025 and Subsequent Highlights Revenues of $142.1 million, up 45.7% from the prior year period Gross Margin

MEXC Launches ETH Launchpad for Ethereum’s 10th Anniversary: Users Share 100 ETH at Up to 90% Off

VICTORIA, Seychelles, July 31, 2025 (GLOBE NEWSWIRE) — MEXC, a leading global cryptocurrency exchange, today announced it has launched its exclusive ETH Launchpad subscription event, offering users the opportunity to share 100 ETH at unprecedented discount rates of up to 90% off in celebration of Ethereum's 10th anniversary. MEXC Launchpad is an innovative token issuance

LexinFintech Holdings Ltd. to Report Second Quarter 2025 Unaudited Financial Results on August 7, 2025

(NASDAQ:LX), SHENZHEN, China, July 31, 2025 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before the U.S. market opens on Thursday, August 7, 2025.

Prospera Energy Inc. Provides Operations Update

(TSX-V:PEI),(Pinksheets:GXRFF),(PinkSheets:GXRFF),(Boerse Frankfurt – Freiverkehr:OF6B),(Boerse Berlin – Freiverkehr:OF6B.BE),(Boerse Stuttgart – Freiverkehr:OF6B.SG),(Boerse Frankfurt – Freiverkehr:OF6B.F), CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) — Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera“, “PEI” or the “Corporation“) Operations UpdateProspera continues to demonstrate strong operational performance, averaging gross production of 859 boe/d (97% oil) from July 1st to July 23rd.

JD.com to Report Second Quarter and Interim 2025 Financial Results on August 14, 2025

(NASDAQ:JD),(HKSE:9618.HK),(HKSE:89618),(HKSE:89618.HK),(HKSE:9618), BEIJING, July 31, 2025 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited financial results for the three months and six months ended June 30, 2025 on Thursday, August 14,

KBR Reports Second Quarter Fiscal 2025 Results

(NYSE:KBR), Second Quarter Fiscal 2025 Highlights(All comparisons against the second quarter fiscal 2024 unless noted.) Revenues of $2.0 billion, up 6% Net income attributable to KBR (including discontinued operations) of $73 million; Adjusted EBITDA2 of $242 million, up 12% with an Adjusted EBITDA2 margin of 12.4% Diluted EPS (including discontinued operations) of $0.56; Adjusted EPS2

Integra LifeSciences Reports Second Quarter 2025 Financial Results

(NASDAQ:IART), PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Second Quarter 2025 Highlights Second quarter revenues exceeded guidance; adjusted earnings per diluted share (EPS) at the top end of the range

ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China

(NASDAQ:TIL), Partial responses observed in 80% of squamous NSCLC front-line patients and in 46% of non-squamous NSCLC front-line patients Safety profile supports further clinical development, with no dose-limiting toxicities observed in patients with front-line NSCLC ImmuneOnco expects to present updated safety and efficacy data at a future medical conference DALLAS and SHANGHAI, July 31, 2025

Scroll to Top